Usual Adult Dose for Postoperative Ocular Inflammation
1 drop in the affected eye, 4 times per day beginning 24 hours after cataract surgery and continuing throughout the first 2 weeks of the post-operative period
Use: Treatment of post-operative inflammation in patients who have undergone cataract extraction
Usual Adult Dose for Inhibition of Intraoperative Miosis
1 or 2 drops in the operative eye within the hour prior to corneal refractive surgery; within 15 minutes after surgery, 1 or 2 drops should be applied to the operative eye and continued 4 times per day for up to 3 days
Use: Temporary relief of pain and photophobia in patients undergoing corneal refractive surgery
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
This drug is for instillation into the conjunctival sac only. It should not be injected subconjunctivally, nor should it be directly introduced into the anterior chamber of the eye.
Patient advice:
To prevent the active substances from being washed out when additional ophthalmic drug is used, an interval of at least 5 minutes between each application should be followed.
Nasolacrimal occlusion or closing the eyes for 3 minutes may reduce the systemic absorption, which may result in a decrease in systemic side effects and an increase in local activity.
Patients with blurred vision or other visual disturbances should avoid driving a vehicle or operating machines until vision improves.
